A - Industry Comparison: Evaluating Agilent Technologies Against Competitors In Life Sciences Tools & Services Industry | Benzinga
In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we will conduct a comprehensive industry comparison, evaluating Agilent Technologies (NYSE:A) against its key competitors in the Life Sciences Tools & Services industry. By examining key financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
Agilent Technologies Background
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
| Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc | |||||||
| 31.52 | |||||||
| 6.25 | |||||||
| 5.94 | |||||||
| 4.97% | |||||||
| $0.46 | |||||||
| $0.86 | |||||||
| -8.39% | |||||||
| Thermo Fisher Scientific Inc | |||||||
| 37.30 | |||||||
| 4.88 | |||||||
| 5.30 | |||||||
| 2.88% | |||||||
| $2.79 | |||||||
| $4.21 | |||||||
| -3.41% | |||||||
| Danaher Corp | |||||||
| 48.56 | |||||||
| 3.67 | |||||||
| 8.32 | |||||||
| 2.04% | |||||||
| $1.92 | |||||||
| $3.49 | |||||||
| -2.57% | |||||||
| IQVIA Holdings Inc | |||||||
| 29.48 | |||||||
| 6.20 | |||||||
| 2.65 | |||||||
| 4.62% | |||||||
| $0.77 | |||||||
| $1.29 | |||||||
| 2.33% | |||||||
| West Pharmaceutical Services Inc | |||||||
| 42.20 | |||||||
| 8.69 | |||||||
| 8.19 | |||||||
| 4.15% | |||||||
| $0.16 | |||||||
| $0.23 | |||||||
| -2.96% | |||||||
| Waters Corp | |||||||
| 29.61 | |||||||
| 14.23 | |||||||
| 6.15 | |||||||
| 8.49% | |||||||
| $0.18 | |||||||
| $0.38 | |||||||
| -22.29% | |||||||
| Avantor Inc | |||||||
| 61.76 | |||||||
| 2.99 | |||||||
| 2.32 | |||||||
| 1.14% | |||||||
| $0.24 | |||||||
| $0.57 | |||||||
| -5.65% | |||||||
| Revvity Inc | |||||||
| 74.35 | |||||||
| 1.72 | |||||||
| 4.98 | |||||||
| 0.33% | |||||||
| $0.17 | |||||||
| $0.36 | |||||||
| -3.7% | |||||||
| Medpace Holdings Inc | |||||||
| 41.35 | |||||||
| 18.71 | |||||||
| 6.57 | |||||||
| 16.67% | |||||||
| $0.11 | |||||||
| $0.16 | |||||||
| 17.73% | |||||||
| Bio-Techne Corp | |||||||
| 61.66 | |||||||
| 6.03 | |||||||
| 10.76 | |||||||
| 2.47% | |||||||
| $0.09 | |||||||
| $0.2 | |||||||
| 3.16% | |||||||
| Charles River Laboratories International Inc | |||||||
| 25.21 | |||||||
| 3.04 | |||||||
| 2.69 | |||||||
| 1.86% | |||||||
| $0.22 | |||||||
| $0.34 | |||||||
| -1.73% | |||||||
| Bruker Corp | |||||||
| 23.80 | |||||||
| 6.95 | |||||||
| 3.18 | |||||||
| 3.65% | |||||||
| $0.11 | |||||||
| $0.35 | |||||||
| 5.31% | |||||||
| Repligen Corp | |||||||
| 522.52 | |||||||
| 4 | |||||||
| 13.06 | |||||||
| 0.11% | |||||||
| $0.02 | |||||||
| $0.07 | |||||||
| -17.14% | |||||||
| Stevanato Group SPA | |||||||
| 33.57 | |||||||
| 3.51 | |||||||
| 4.19 | |||||||
| 1.53% | |||||||
| $0.05 | |||||||
| $0.06 | |||||||
| -0.84% | |||||||
| Sotera Health Co | |||||||
| 62.89 | |||||||
| 7.88 | |||||||
| 3.15 | |||||||
| 1.44% | |||||||
| $0.09 | |||||||
| $0.13 | |||||||
| 12.51% | |||||||
| Average | |||||||
| 78.16 | |||||||
| 6.61 | |||||||
| 5.82 | |||||||
| 3.67% | |||||||
| $0.49 | |||||||
| $0.85 | |||||||
| -1.38% |